Why Honeywell just shaved about $600 million off the price of a chemicals acquisition
By Steve Goldstein
Honeywell agreed to a lowered price on Johnson Matthey's catalyst technology business.
A previous headline on this report inaccurately expressed a price change as being in dollars when it is actually in sterling. The story has been corrected.
Honeywell International on Monday received a 26% discount on its deal to acquire a business tied to the struggling chemicals industry.
Johnson Matthey said it's lowering the sale price of the catalyst technology business it's selling to Honeywell to GBP1.325 billion ($1.8 billion) from GBP1.8 billion, citing its recent business performance, including the deferral of key sustainable solution licensing projects and a challenging market environment.
It's also giving Honeywell more time to complete the deal.
The news fits with Friday's move by LyondellBasell (LYB) to cut its dividend in half, again citing challenging market conditions.
Honeywell already sells catalyst and process technologies, and for the U.S. company, the acquisition is a chance to expand its base to refining and petrochemical customers as well as offer customers a complete solution for the production of lower emission fuels, like sustainable aviation fuel.
Johnson Matthey in response is cutting its capital-return plan to GBP1 billion from GBP1.4 billion.
Honeywell shares (HON) were steady in premarket trade.
Johnson Matthey (UK:JMAT) stock tumbled 15% in London trade.
"While the revised consideration is clearly not an optimal outcome, it remains more favorable than weekend reports suggesting Honeywell was considering terminating the deal," said analysts at Jefferies of Johnson Matthey's situation.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-23-26 0823ET
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
